Mode
Text Size
Log in / Sign up
Dr. Julia Lee, PhD
Medical Editor

Dr. Julia Lee, PhD

Oncology, Genomics & Drug Development — Molecular targets, biomarker-stratified trials, accelerated-approval pathways.

Dr. Julia Lee is a freelance medical writer specializing in Oncology, Genomics & Drug Development, with over 10+ years of experience spanning academic research, translational science, and scientific communication. She holds a PhD in Cancer Biology from Stanford University School of Medicine, with additional training in molecular biology, genomics, and translational oncology. She also holds certification in Good Clinical Practice (ICH-GCP) and has completed advanced professional training in medical writing and regulatory communication.

Her research background includes work on tumor microenvironment biology and treatment-related toxicity, with a strong focus on biomarker-driven oncology and precision medicine approaches.

Julia supports biopharmaceutical organizations in developing scientific content for molecularly targeted therapies, biomarker-stratified clinical trials, and drug development programs, including accelerated approval pathways. Her work spans scientific publications, clinical communication materials, and translational research documentation.

Articles in this group — last 14 days

No established correlation exists between paragangliomas and cervical lymph node metastasis in papillary thyroid carcinoma
Oncology Sys. Review
No established correlation exists between paragangliomas and cervical lymph node metastasis in papillary thyroid carcinoma Distinguishing Between Thyroid Cancer and Paraganglioma for Better Diagnosis
This case report and literature review examines the relationship between paragangliomas and cervical lymph node metastasis in patients with …
Doctors must accurately distinguish between thyroid cancer and paragangliomas to ensure correct treatment plans and accurate patient prognos…
Local therapy and intrathecal chemotherapy may manage CNS progression in EGFR-mutant NSCLC patients
Oncology Sys. Review
Local therapy and intrathecal chemotherapy may manage CNS progression in EGFR-mutant NSCLC patients Combined Treatments May Help Manage Brain Metastases in Lung Cancer
This case report and literature review describes a patient with EGFR-mutant NSCLC and brain/leptomeningeal metastases. The authors suggest t…
A new treatment approach combining surgery, local chemotherapy, and targeted drugs may help manage brain cancer spread for some patients.
Preoperative inflammatory biomarkers SIRI and NLR associate with worse survival in UTUC after RNU
Oncology Meta-analysis
Preoperative inflammatory biomarkers SIRI and NLR associate with worse survival in UTUC after RNU Inflammatory Biomarkers Linked to Outcomes in Upper Tract Urothelial Carcinoma
This systematic review and meta-analysis of 7,346 patients found that preoperative systemic inflammatory biomarkers, specifically SIRI (HR 2…
Specific inflammatory markers in the blood may be linked to survival outcomes for patients with upper tract urothelial carcinoma.
Mindfulness-based stress reduction significantly reduces anxiety, depression, and fatigue in breast cancer patients
Oncology Meta-analysis
Mindfulness-based stress reduction significantly reduces anxiety, depression, and fatigue in breast cancer patients Mindfulness Training May Improve Quality of Life in Breast Cancer
This meta-analysis of 20 studies involving 2534 patients found that mindfulness-based stress reduction (MBSR) significantly alleviated anxie…
A review of research suggests that mindfulness programs can help breast cancer patients manage anxiety, depression, and fatigue during treat…
Fine-tuned BioBERT achieves 96% F1-score for named-entity recognition in microbiome literature
Genetics & Precision Medicine Meta-analysis
Fine-tuned BioBERT achieves 96% F1-score for named-entity recognition in microbiome literature Deep Learning Models Improve Accuracy in Microbiome Data Extraction
This methodological meta-analysis evaluated deep learning models for named-entity recognition and entity linking in microbiome literature. A…
New deep learning models show higher accuracy and faster speeds when identifying key terms in complex microbiome research documents.
Sinonasal NUT carcinoma with leptomeningeal carcinomatosis may require early multimodal treatment and surgical intervention
Oncology Sys. Review
Sinonasal NUT carcinoma with leptomeningeal carcinomatosis may require early multimodal treatment and surgical intervention New case shows how certain nasal cancers spread to brain lining
This case report and review describes a 32-year-old woman with sinonasal NUT carcinoma who developed leptomeningeal carcinomatosis. The auth…
A rare nose and sinus cancer can spread quickly to the brain's lining, making early diagnosis and surgery vital for patient survival.
Metabolic reprogramming and plasticity drive tumor progression and resistance through interconnected transcription factors and enzymes
Oncology Sys. Review
Metabolic reprogramming and plasticity drive tumor progression and resistance through interconnected transcription factors and enzymes Metabolic Plasticity Drives Cancer Growth and Resistance
This narrative review examines how metabolic reprogramming, driven by transcription factors like MYC and HIF-1α, facilitates cancer progress…
Cancer cells rewire their metabolism to fuel growth and resist treatment. A new review maps the complex network behind this process.
Lenvatinib plus pembrolizumab did not improve overall survival compared to standard of care
Oncology RCT
Lenvatinib plus pembrolizumab did not improve overall survival compared to standard of care Trial shows lenvatinib and pembrolizumab do not improve survival
This Phase 2 randomized trial evaluated lenvatinib and pembrolizumab in 374 adults with recurrent or metastatic head and neck squamous cell …
A Phase 2 trial found that a combination of lenvatinib and pembrolizumab did not improve overall survival for patients with advanced head an…
Alectinib improves progression-free survival over crizotinib in ALK-positive NSCLC (HR 0.41)
Oncology Phase III
Alectinib improves progression-free survival over crizotinib in ALK-positive NSCLC (HR 0.41) Alectinib Shows Better Progression-Free Survival Than Crizotinib for NSCLC
This pooled analysis of Phase III trials involving 500 patients with ALK-positive NSCLC found that alectinib significantly improved progress…
Alectinib showed better progression-free survival than crizotinib in a study of 500 patients with ALK-positive lung cancer.
Daraxonrasib improves overall survival to 13.2 months in mPDAC patients compared to 6.7 months
Oncology RCT
Daraxonrasib improves overall survival to 13.2 months in mPDAC patients compared to 6.7 months Trial shows daraxonrasib improves survival for pancreatic cancer patients
This Phase 3 randomized trial of 500 patients with previously treated metastatic pancreatic ductal adenocarcinoma found daraxonrasib signifi…
A Phase 3 trial found that daraxonrasib significantly extended survival times for patients with specific types of metastatic pancreatic canc…
DNA Methylation Tests Show High Accuracy for Cervical Cancer Triage
Oncology Meta-analysis
DNA Methylation Tests Show High Accuracy for Cervical Cancer Triage DNA methylation tests show promise for identifying high grade cervical cell changes
Meta-analysis of 28,977 HPV+ women finds DNA methylation markers like JAM3 and PAX1 have high diagnostic odds ratios for detecting CIN2+.
New tests looking at DNA markers can help doctors find serious cervical cell changes more accurately than some current methods.
Minimally invasive pancreaticoduodenectomy reduces blood loss and hospital stay in distal cholangiocarcinoma surgery
Oncology Meta-analysis
Minimally invasive pancreaticoduodenectomy reduces blood loss and hospital stay in distal cholangiocarcinoma surgery Minimally invasive surgery shows benefits for certain bile duct cancer
This meta-analysis of retrospective cohort studies evaluates minimally invasive pancreaticoduodenectomy (MIPD) compared to open pancreaticod…
Minimally invasive surgery can reduce blood loss and hospital stays for patients undergoing surgery for distal cholangiocarcinoma.
LAMS and BFMS show higher clinical success rates than DPPS for pancreatic fluid collections
Oncology Sys. Review
LAMS and BFMS show higher clinical success rates than DPPS for pancreatic fluid collections New data reveals better stent options for pancreatic fluid collections
This network meta-analysis of 38 studies included 4265 patients with pancreatic fluid collections (PFCs) to compare various drainage methods…
Different types of stents offer varying success rates and safety profiles for patients with complex drainage needs after pancreatic issues.
Circulating microRNAs and lipidomic/metabolomic biomarkers show 0.92 SROC AUC for early breast cancer detection
Oncology Meta-analysis
Circulating microRNAs and lipidomic/metabolomic biomarkers show 0.92 SROC AUC for early breast cancer detection Blood markers show promise for early breast cancer detection
This meta-analysis of 6,935 participants evaluated the diagnostic accuracy of circulating microRNAs and lipidomic/metabolomic biomarkers in …
A new analysis of 35 studies finds that blood-based biomarkers can detect early breast cancer with high accuracy, but more research is neede…
5-ALA fluorescence-guided surgery improves gross total resection rates in patients with glioblastoma
Oncology Meta-analysis
5-ALA fluorescence-guided surgery improves gross total resection rates in patients with glioblastoma Fluorescence guided surgery improves tumor removal for glioblastoma patients
This meta-analysis of 790 patients found that 5-ALA guided surgery significantly improved gross total resection (RR = 1.54, 95% CI: 1.16-2.0…
A special light guide helps surgeons remove more of a brain tumor while keeping patient safety and recovery rates steady.
Guselkumab, Secukinumab, and Brodalumab rank highly for PASI 75 and PASI 90 in plaque psoriasis
Oncology Meta-analysis
Guselkumab, Secukinumab, and Brodalumab rank highly for PASI 75 and PASI 90 in plaque psoriasis New data ranks different treatments for moderate to severe psoriasis
This systematic review and network meta-analysis of 27 RCTs evaluated IL-23/IL-17 inhibitors for moderate-to-severe plaque psoriasis. Guselk…
Comparing several types of biologics helps patients with plaque psoriasis find which medications rank highest for clearing skin and improvin…
Recurrent intracranial dermoid cysts may cause delayed hydrocephalus following spontaneous rupture and ventricular dissemination
Oncology Sys. Review
Recurrent intracranial dermoid cysts may cause delayed hydrocephalus following spontaneous rupture and ventricular dissemination New Case Report Highlights Risks of Ruptured Brain Dermoid Cysts
This narrative review and case report describe the clinical features of a ruptured, recurrent intracranial dermoid cyst. The authors highlig…
A rare case of a ruptured brain cyst highlights the risk of delayed complications like hydrocephalus after initial surgery.
Adenomatoid tumor should be considered in the differential diagnosis for testicular lesions in patients with cryptorchidism
Oncology Sys. Review
Adenomatoid tumor should be considered in the differential diagnosis for testicular lesions in patients with cryptorchidism Testicular Adenomatoid Tumor Linked to History of Cryptorchidism
This case report and literature review describes a 58-year-old man with cryptorchidism, male breast cancer, and thymic B2 thymoma who presen…
A new case report highlights a link between undescended testes and certain benign testicular tumors, helping doctors better identify similar…
CAR T-cell therapies targeting specific antigens show potential for treating pediatric CNS tumors
Oncology Sys. Review
CAR T-cell therapies targeting specific antigens show potential for treating pediatric CNS tumors New CAR T-cell therapies show promise for pediatric brain tumors
This narrative review synthesizes 18 studies, including preclinical and early-phase clinical trials, regarding CAR T-cell therapy for pediat…
CAR T-cell therapy is showing potential to shrink tumors and extend life in children with aggressive brain cancers like DIPG.
SDHD Variant Carriers Face High Penetrance and Multifocal Tumors
Oncology Meta-analysis
SDHD Variant Carriers Face High Penetrance and Multifocal Tumors SDHD Genetic Variants Linked to Increasing Risk of Tumors Over Time
A meta-analysis of SDHD pathogenic variant carriers reveals age-specific penetrance rising to 82% by age 60, with 75% developing multifocal …
New data shows that the risk of developing tumors increases significantly with age for people carrying specific SDHD genetic variants.
Transsphenoidal surgery achieves 73.88% remission rate in Cushing's Disease
Oncology Meta-analysis
Transsphenoidal surgery achieves 73.88% remission rate in Cushing's Disease Factors linked to higher remission rates in Cushing's Disease surgery
A meta-analysis of 11,666 patients with Cushing's Disease found that transsphenoidal surgery yields an overall remission rate of 73.88%. Hig…
New data identifies specific surgical and imaging factors that may help doctors predict better outcomes for patients undergoing surgery for …
Age over 50 and alcohol use are risk factors for severe orlistat-induced liver injury
Drug Pipeline Sys. Review
Age over 50 and alcohol use are risk factors for severe orlistat-induced liver injury Risk Factors for Liver Injury Linked to Orlistat Use
This systematic review of case reports examines the clinical spectrum and risk factors for orlistat-induced liver injury (OILI). The analysi…
Specific risk factors like age and alcohol use may increase the chance of severe liver issues in patients taking the weight loss medication …
Berberine exhibits antimicrobial and anti-inflammatory effects for managing various oral mucosal and dental conditions
Drug Pipeline Sys. Review
Berberine exhibits antimicrobial and anti-inflammatory effects for managing various oral mucosal and dental conditions Berberine Shows Potential for Treating Various Oral Health Conditions
This systematic review synthesizes the pharmacological properties of berberine in treating oral diseases including periodontitis, caries, an…
A review of berberine suggests it may help manage oral diseases like periodontitis and dental caries through its anti-inflammatory and antio…
Intra-arterial alteplase and tenecteplase improve excellent functional outcomes after endovascular thrombectomy for stroke
Drug Pipeline Meta-analysis
Intra-arterial alteplase and tenecteplase improve excellent functional outcomes after endovascular thrombectomy for stroke Adding certain clot-busting drugs improves outcomes for stroke patients
This network meta-analysis of 2,131 patients with acute ischemic stroke caused by large-vessel occlusion found that intra-arterial thromboly…
Combining mechanical removal of blood clots with specific medications can significantly improve recovery for patients with severe strokes.
Natural compounds may alleviate anesthesia induced cognitive dysfunction through multi-target regulatory mechanisms
Drug Pipeline Sys. Review
Natural compounds may alleviate anesthesia induced cognitive dysfunction through multi-target regulatory mechanisms Natural Compounds May Help Protect Brains After Anesthesia
This systematic review evaluates 16 natural compounds, including flavonoids and polyphenols, regarding their role in mitigating anesthetic-i…
Certain natural compounds like flavonoids and polyphenols may help protect brain function from damage caused by inhalational anesthetics.
Prodigiosin shows theoretical potential as a radiosensitiser for glioblastoma based on multifaceted cytotoxic activity
Drug Pipeline Sys. Review
Prodigiosin shows theoretical potential as a radiosensitiser for glioblastoma based on multifaceted cytotoxic activity Prodigiosin Shows Potential as a Treatment for Glioblastoma
This narrative review explores the biological profile of prodigiosin (PG) in the context of glioblastoma. The authors suggest PG may act as …
A new review suggests that the compound prodigiosin could help make radiation more effective against glioblastoma brain tumors.
Shenmai and Shenfu injections may reduce postoperative cognitive dysfunction incidence following surgical procedures
Drug Pipeline Meta-analysis
Shenmai and Shenfu injections may reduce postoperative cognitive dysfunction incidence following surgical procedures Two injections may help patients recover mental clarity after surgery
This meta-analysis of 16 RCTs involving 1,199 patients indicates that Shenmai and Shenfu injections are associated with higher MMSE scores a…
New data suggests that Shenmai and Shenfu injections could help patients regain mental clarity and awareness more quickly after undergoing s…
Daridorexant improves objective and subjective insomnia markers with dose-dependent efficacy across multiple trials
Drug Pipeline Meta-analysis
Daridorexant improves objective and subjective insomnia markers with dose-dependent efficacy across multiple trials New data shows daridorexant helps people with insomnia sleep better
This meta-analysis of 2905 patients found that daridorexant outperformed placebo in both objective and subjective sleep indicators for insom…
Daridorexant shows promise for treating insomnia by improving sleep time and quality, though some side effects are linked to specific doses.
Targeting protein acylation modifications via SIRT1 and HDACs may mitigate myocardial injury and inflammation
Drug Pipeline Sys. Review
Targeting protein acylation modifications via SIRT1 and HDACs may mitigate myocardial injury and inflammation New ways to treat heart failure through protein modifications
This narrative review explores how protein acylation modifications, including acetylation and lactylation, regulate metabolic signaling in c…
Scientists identify how targeting specific protein changes can help repair heart tissue and reduce inflammation in patients with heart disea…
Preliminary evidence suggests therapeutic drug monitoring of sertraline may guide clinical judgment in specific populations
Drug Pipeline Meta-analysis
Preliminary evidence suggests therapeutic drug monitoring of sertraline may guide clinical judgment in specific populations TDM Monitoring May Help Guide Sertraline Use for OCD Patients
This scoping review examined the clinical utility of sertraline therapeutic drug monitoring (TDM) for individuals with depression and obsess…
Monitoring blood levels of the medication sertraline might help doctors manage treatment for patients with depression and obsessive-compulsi…
Zebrafish serve as versatile in vivo pharmacological platforms for evaluating multi-target interactions of TCM formulas
Drug Pipeline Sys. Review
Zebrafish serve as versatile in vivo pharmacological platforms for evaluating multi-target interactions of TCM formulas Zebrafish Provide New Way to Study Traditional Chinese Medicine
This systematic review evaluates the use of zebrafish as a pharmacological platform to study Traditional Chinese Medicine (TCM). The authors…
Researchers are using zebrafish as a versatile platform to study how traditional herbal medicines affect heart rates, immune cells, and tumo…
Successful radiation oncology AI integration requires trustworthy ecosystems and human-centered workflow design
Oncology Sys. Review
Successful radiation oncology AI integration requires trustworthy ecosystems and human-centered workflow design Factors Influencing Success of Artificial Intelligence in Radiation Oncology
This narrative review examines the role of artificial intelligence in radiation oncology workflows. The authors argue that clinical success …
Successful use of artificial intelligence in radiation oncology depends on creating trustworthy systems that integrate with human expertise …
Endoscopic resection followed by esophagectomy shows favorable recurrence-free and disease-specific survival in superficial esophageal cancer
Oncology Meta-analysis
Endoscopic resection followed by esophagectomy shows favorable recurrence-free and disease-specific survival in superficial esophageal cancer Combined endoscopic surgery and esophagectomy may improve cancer outcomes
This systematic review and network meta-analysis of 2,621 patients with high-risk superficial esophageal cancer found that endoscopic resect…
A new analysis suggests that combining endoscopic resection with surgery could help patients with high-risk esophageal cancer live longer wi…
Comparative Efficacy of Immunotherapy Combinations in Advanced Renal Cell Carcinoma Management
Oncology Sys. Review
Comparative Efficacy of Immunotherapy Combinations in Advanced Renal Cell Carcinoma Management New analysis compares immunotherapy combinations for advanced renal cell carcinoma
A network meta-analysis evaluates diverse immunotherapy combinations for advanced renal cell carcinoma, highlighting specific survival benef…
A large review of over 6,000 patients identifies specific immunotherapy combinations that may improve survival for those with advanced kidne…
Bibliometric Analysis Maps Paraptosis Research Landscape in Cancer
Oncology Sys. Review
Bibliometric Analysis Maps Paraptosis Research Landscape in Cancer Mapping the Research Landscape of Paraptosis in Cancer Treatment
A bibliometric analysis of 401 publications reveals rising interest in paraptosis, a non-apoptotic cell death pathway, with China and Ajou U…
A review of 401 publications shows a significant rise in research on paraptosis, a specific type of cell death that may impact cancer treatm…
Oral propranolol remains the primary systemic treatment for infantile hemangioma with no superior alternatives
Oncology Sys. Review
Oral propranolol remains the primary systemic treatment for infantile hemangioma with no superior alternatives Propranolol Remains the Standard Treatment for Infantile Hemangioma
This meta-analysis of 2639 patients found that no active intervention, including corticosteroids or other beta-blockers, demonstrated statis…
A review of over 2,600 cases shows that while several drugs treat infantile hemangioma, oral propranolol remains a primary standard.
Soluble CD146 serves as a marker of microvascular stress and promotes tumor invasion
Oncology Sys. Review
Soluble CD146 serves as a marker of microvascular stress and promotes tumor invasion Soluble CD146 May Help Identify Cancer and Heart Stress
This systematic review examines the role of soluble CD146 (sCD146) in malignant solid tumors and cardiovascular diseases. The authors conclu…
A protein called sCD146 may help doctors identify cancer cell behavior and track stress in heart and lung tissues.
CXCL16/CXCR6 axis exerts bidirectional regulatory influence on neoplasms and inflammatory disorders like asthma
Oncology Sys. Review
CXCL16/CXCR6 axis exerts bidirectional regulatory influence on neoplasms and inflammatory disorders like asthma New Biological Pathways May Help Doctors Treat Cancer and Asthma Better
This narrative review examines the CXCL16/CXCR6 axis as a multifaceted regulator in various pathological processes, including neoplasms and …
Scientists are looking at how a specific protein pathway can influence both cancer growth and lung inflammation.
Evidence-based guidelines support team-based perioperative glycemic management for patients with hepatocellular carcinoma
Oncology Meta-analysis
Evidence-based guidelines support team-based perioperative glycemic management for patients with hepatocellular carcinoma New guidance for blood sugar control before liver cancer surgery
This evidence summary synthesizes 14 documents, including guidelines and randomized controlled trials, to provide guidance on perioperative …
A new evidence summary offers 28 best practice items for managing blood sugar in liver cancer patients before, during, and after surgery.
Immune checkpoint inhibitors plus chemotherapy improve overall survival in advanced triple-negative breast cancer
Oncology Meta-analysis
Immune checkpoint inhibitors plus chemotherapy improve overall survival in advanced triple-negative breast cancer Immunotherapy plus chemo improves survival in triple-negative breast cancer
This umbrella meta-analysis of 39,147 patients found that combining immune checkpoint inhibitors with chemotherapy significantly improves ov…
Adding immunotherapy to chemo helps some patients with advanced triple-negative breast cancer live longer, but side effects are more common.
HPV shows strong association with oropharyngeal SCC while other oncogenic viruses show limited evidence
Oncology Meta-analysis
HPV shows strong association with oropharyngeal SCC while other oncogenic viruses show limited evidence Viruses linked to oral and throat cancers in new review
This systematic review examines the role of various oncogenic viruses in oral and oropharyngeal squamous cell carcinomas. It identifies a co…
A strong link between HPV and throat cancer is confirmed, while other viruses show less clear evidence of causing cancer.
FDA Approves Ogsiveo (nirogacestat) for Progressing Desmoid Tumors
Oncology FDA Approval
FDA Approves Ogsiveo (nirogacestat) for Progressing Desmoid Tumors FDA approves Ogsiveo, first drug for rare desmoid tumors
FDA approved Ogsiveo for adult patients with progressing desmoid tumors who require systemic treatment. Approval based on DeFi trial showing…
The FDA approved Ogsiveo (nirogacestat) for adults with progressing desmoid tumors who need systemic treatment. This is the first drug speci…
Internal mammary and medial-supraclavicular irradiation reduces breast cancer mortality without improving overall survival
Oncology RCT
Internal mammary and medial-supraclavicular irradiation reduces breast cancer mortality without improving overall survival Trial shows specific radiation reduces breast cancer deaths over 20 years
This trial evaluated internal mammary and medial-supraclavicular irradiation for patients with early stage breast cancer. While the interven…
A long-term study of over 4,000 women found that a specific radiation technique lowered breast cancer deaths but did not change overall surv…
DEB-BACE Shows Higher Short-Term Response in Unresectable Lung Cancer
Oncology Meta-analysis
DEB-BACE Shows Higher Short-Term Response in Unresectable Lung Cancer Drug Eluting Beads May Improve Treatment Success for Certain Lung Cancer Patients
A meta-analysis of 221 patients found that drug-eluting beads bronchial arterial chemoembolization (DEB-BACE) improves short-term tumor resp…
A new review shows that using drug-eluting beads during a specific procedure may help shrink tumors more effectively than standard methods.
Robotic-assisted thoracoscopic segmentectomy increases lymph node stations examined and reduces hospital stay duration
Oncology Meta-analysis
Robotic-assisted thoracoscopic segmentectomy increases lymph node stations examined and reduces hospital stay duration Robotic surgery may help lung cancer patients stay in hospital less
This meta-analysis of 19,805 patients with early-stage NSCLC compares robotic-assisted thoracoscopic segmentectomy (RATS) to video-assisted …
A large review suggests robotic-assisted surgery for early-stage lung cancer can lead to more lymph node checks and shorter hospital stays.
Comparative Analysis of Robot Assisted and Laparoscopic Partial Nephrectomy for Renal Tumors
Oncology Meta-analysis
Comparative Analysis of Robot Assisted and Laparoscopic Partial Nephrectomy for Renal Tumors Robot-assisted surgery shows fewer complications for certain kidney tumors
A meta-analysis of 6,202 patients suggests robot-assisted partial nephrectomy offers comparable oncologic outcomes with superior renal prese…
A large review suggests robot-assisted surgery may lead to less blood loss and better kidney function for patients with specific renal tumor…
Retroperitoneal approach in single-port robot-assisted partial nephrectomy may reduce blood loss and hospital stay
Oncology Meta-analysis
Retroperitoneal approach in single-port robot-assisted partial nephrectomy may reduce blood loss and hospital stay Retroperitoneal approach may offer benefits for kidney cancer surgery
This meta-analysis of 384 patients compares transperitoneal and retroperitoneal approaches for single-port robot-assisted partial nephrectom…
A new look at surgical methods suggests the retroperitoneal approach may reduce blood loss and hospital stays for patients with renal cancer…
First-line immune checkpoint inhibitor therapy improves progression-free survival and overall survival in MSI-H/dMMR mCRC
Oncology Meta-analysis
First-line immune checkpoint inhibitor therapy improves progression-free survival and overall survival in MSI-H/dMMR mCRC Immune checkpoint inhibitors improve survival for certain colorectal cancers
This meta-analysis of more than 600 patients with metastatic colorectal cancer (mCRC) involving microsatellite instability-high or mismatch …
New analysis shows immune checkpoint inhibitors offer better survival and fewer side effects than chemotherapy for specific types of metasta…
Forty-seven clinically relevant late-phase programs identify development trajectories for PD-1 and PD-L1 therapies through 2030
Oncology Sys. Review
Forty-seven clinically relevant late-phase programs identify development trajectories for PD-1 and PD-L1 therapies through 2030 47 late-phase programs aim to improve PD-1/PD-L1 cancer therapies
This narrative review analyzes registry-derived clinical trial data to identify future directions for PD-1 and PD-L1 inhibitor therapies. Th…
A new review maps 47 late-phase programs working to overcome limits of PD-1/PD-L1 cancer treatments through 2030.
Multimodal fusion and radiogenomic frameworks show promise for capturing heterogeneity in triple-negative breast cancer
Oncology Sys. Review
Multimodal fusion and radiogenomic frameworks show promise for capturing heterogeneity in triple-negative breast cancer Artificial Intelligence Shows Promise in Triple-Negative Breast Cancer Care
This narrative synthesis reviews the application of artificial intelligence across radiology, digital pathology, and multi-omics for triple-…
New research shows how artificial intelligence can help identify cancer subtypes and predict treatment responses for patients with triple-ne…
Paclitaxel arm achieves 56.4% pathologic complete response compared to 23.7% with endocrine therapy
Oncology RCT
Paclitaxel arm achieves 56.4% pathologic complete response compared to 23.7% with endocrine therapy Trial shows chemotherapy helps shrink early breast cancer more effectively
This Phase II multicenter randomized trial evaluated neoadjuvant trastuzumab and pertuzumab combined with either endocrine therapy or paclit…
A new trial compares using standard chemotherapy versus hormone therapy to shrink tumors before surgery in patients with HER2-positive breas…
Multifaceted preventive nursing program reduces fall incidence from 19.8% to 7.1% in elderly NHL patients
Oncology RCT
Multifaceted preventive nursing program reduces fall incidence from 19.8% to 7.1% in elderly NHL patients Nursing Program Reduces Fall Risk for Lymphoma Patients
This randomized controlled trial of 210 older adults with non-Hodgkin's lymphoma found that a multifaceted preventive nursing program signif…
A specialized nursing program significantly reduced falls and improved mobility for older adults undergoing chemotherapy for lymphoma.
5-ALA PDT improves overall response and HPV clearance in cervical squamous intraepithelial lesions
Oncology Meta-analysis
5-ALA PDT improves overall response and HPV clearance in cervical squamous intraepithelial lesions Photodynamic therapy shows promise for cervical squamous intraepithelial lesions
This meta-analysis of 3,354 patients evaluated 5-aminolevulinic acid photodynamic therapy (5-ALA PDT) for cervical squamous intraepithelial …
A new treatment method using light and a specific compound may improve response rates and clear HPV infections in patients with cervical les…
FDA Approves Retevmo (selpercatinib) for RET-Driven Cancers
Oncology FDA Approval
FDA Approves Retevmo (selpercatinib) for RET-Driven Cancers FDA approves new drug Retevmo for certain lung and thyroid cancers.
FDA approved Retevmo (selpercatinib) for adult and pediatric patients with RET fusion-positive NSCLC, RET-mutant MTC, RET fusion-positive th…
The FDA approved Retevmo (selpercatinib) for adults with a type of lung cancer that has a specific gene change, and for children and adults …
FDA Approves Retevmo (selpercatinib) for RET Fusion-Positive Solid Tumors
Oncology FDA Approval
FDA Approves Retevmo (selpercatinib) for RET Fusion-Positive Solid Tumors FDA approves Retevmo for more cancers with RET gene fusions
The FDA approved Retevmo (selpercatinib) for adult and pediatric patients 2 years and older with RET fusion-positive solid tumors that have …
The FDA approved Retevmo (selpercatinib) for adults and children ages 2 and older with advanced solid tumors that have a RET gene fusion and…
BIRC3::MALT1 fusion detected in 35% of cells in pulmonary MALT lymphoma case
Oncology Sys. Review
BIRC3::MALT1 fusion detected in 35% of cells in pulmonary MALT lymphoma case Case Report Shows Pulmonary MALT Lymphoma Diagnosis in Lung Nodule
This case report describes a 49-year-old man with pulmonary MALT lymphoma and a BIRC3::MALT1 fusion. The report highlights that mild FDG upt…
A rare type of lymphoma was identified in a 49-year-old man, highlighting the importance of tissue samples when interpreting imaging results…
Indefinite-duration lenalidomide maintenance shows no significant difference in overall survival compared to fixed-duration
Oncology RCT
Indefinite-duration lenalidomide maintenance shows no significant difference in overall survival compared to fixed-duration Trial compares continuous versus fixed duration lenalidomide for myeloma
This Phase 3 randomized trial of 516 patients with standard-risk newly diagnosed multiple myeloma found that indefinite-duration lenalidomid…
A large trial found that continuing lenalidomide treatment indefinitely did not improve overall survival compared to a fixed two-year plan.
AI plus celecoxib more than doubles odds of clinical response in ER-positive breast cancer
Oncology RCT
AI plus celecoxib more than doubles odds of clinical response in ER-positive breast cancer Adding celecoxib to hormone therapy improves early breast cancer response
This Phase III randomized trial of 269 postmenopausal women with ER-positive resectable breast cancer found that adding celecoxib to an arom…
A new trial shows that adding the drug celecoxib to standard hormone therapy can improve initial clinical responses in postmenopausal women …
Endoscopic transsphenoidal surgery increases gross total resection rates for pituitary tumors compared to microscopic techniques
Oncology Meta-analysis
Endoscopic transsphenoidal surgery increases gross total resection rates for pituitary tumors compared to microscopic techniques Endoscopic surgery shows higher removal rates for pituitary tumors
This meta-analysis of 26,295 patients compares endoscopic and microscopic transsphenoidal pituitary surgery. The analysis found higher rates…
Doctors find that endoscopic surgery helps remove more of a pituitary tumor while keeping the same level of safety as traditional methods.
Problem-focused coping is moderately to strongly associated with benefit finding in adult cancer patients
Oncology Meta-analysis
Problem-focused coping is moderately to strongly associated with benefit finding in adult cancer patients Specific coping strategies may help cancer patients find meaning
This meta-analysis of 6078 adult cancer patients found that problem-focused coping was moderately to strongly associated with benefit findin…
New data shows that focusing on practical problems and positive emotions can help people with cancer find more benefit in their lives.